Smith & Nephew Share Price (SN.)

Show Chart Filters
Time period:
Moving Average:
Compare to:
Price 1,892.00on 17-01-2020 at 16:30:00
Change 18.00 0.96%
Buy 1,892.50
Sell 1,891.00
Buy / Sell SN. Shares
Sponsored Financial Content
Last Trade: Buy 36 at 1,897.806p
Day's Volume: 1,221,701
Last Close: 1,874.00p
Open: 1,888.50p
ISIN: GB0009223206
Day's Range 1,878.50p - 1,899.00p
52wk Range: 1,402.00p - 1,998.00p
Market Capitalisation: £16,556m
VWAP: 1,891.659p
Shares in Issue: 875m

Recent Trades History Smith & Nephew (SN.)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy*361,897.806Ordinary
17:44:57 - 17-Jan-20
Sell*3721,879.868Ordinary
17:33:50 - 17-Jan-20
Sell*9,1021,883.908Ordinary
17:31:30 - 17-Jan-20
Buy*3091,892.91Ordinary
17:27:38 - 17-Jan-20
Sell*11,1391,886.421Ordinary
17:18:08 - 17-Jan-20
Buy*3,0001,894.642Ordinary
17:17:46 - 17-Jan-20
Buy*1,8741,893.004Ordinary
17:20:49 - 17-Jan-20
Buy*1,7581,893.004Ordinary
17:20:43 - 17-Jan-20
Sell*2,2971,889.657Ordinary
17:16:31 - 17-Jan-20
Sell*8261,890.45Ordinary
17:16:19 - 17-Jan-20

Share Price History for Smith & Nephew

Time period:
to
Date Open High Low Close
15th Jan 2020 (Wed)1,880.001,894.501,878.001,885.50
14th Jan 2020 (Tue)1,865.001,878.001,860.001,874.00
13th Jan 2020 (Mon)1,870.001,880.001,866.001,870.75
10th Jan 2020 (Fri)1,853.001,868.001,850.001,865.00
9th Jan 2020 (Thu)1,833.501,858.001,833.501,847.50
8th Jan 2020 (Wed)1,822.001,834.001,817.001,831.75
7th Jan 2020 (Tue)1,827.501,839.001,816.001,828.50
6th Jan 2020 (Mon)1,822.501,835.001,812.001,812.25
3rd Jan 2020 (Fri)1,839.501,847.001,827.001,841.25
2nd Jan 2020 (Thu)1,823.501,848.001,822.501,834.75
1st Jan 2020 (Wed)1,844.500.000.001,831.00
31st Dec 2019 (Tue)1,844.501,857.501,826.501,831.00
30th Dec 2019 (Mon)1,856.001,865.001,844.001,844.50
27th Dec 2019 (Fri)1,840.001,866.001,837.001,857.00
26th Dec 2019 (Thu)00.000.001,877.25
25th Dec 2019 (Wed)1,865.500.000.001,877.25
24th Dec 2019 (Tue)1,865.501,880.001,852.501,877.25
23rd Dec 2019 (Mon)1,835.501,872.001,833.001,862.25
20th Dec 2019 (Fri)1,821.001,842.001,811.501,832.75
19th Dec 2019 (Thu)1,809.001,837.501,801.001,837.00
18th Dec 2019 (Wed)1,809.501,821.001,790.001,807.75
17th Dec 2019 (Tue)1,775.001,805.001,766.001,798.00

SN. - Smith & Nephew Investor Summary

Smith & Nephew are presently the UK's largest medical technology company and one of global significance in its specialised field. Established over 150 years ago, the company now operates in over 30 countries worldwide, with their headquarters still being in London, UK. Their main focus revolves around developing and promoting novel products to help physicians treat aging patients with endoscopy techniques, orthopaedic reconstruction, trauma and advanced wound management being at the forefront of their research. The company feel that the increasingly aging population equals a significant growth potential for the already established markets of orthopaedics, endoscopy and wound management around the world.

Today, Smith & Nephew have over 1000 products in their arsenal and generate worldwide sales of over 3.4 billion dollars. They further report that over the last 5 years their revenues have grown from around nineteen hundred million dollars to over thirty three hundred million dollars – a percentage increase of nearly 100%. This success has been helped along by the launch of a new range of ingenious wound dressing products in 2008 and the acquisition of the Swiss company Plus Orthopaedics Holdings AG in 2007. Smith & Nephew research, develop and manufacture a number of new orthopaedic and wound management products each year, many of which quickly become established products within the UK and the US. The share price of this major medtech company has stayed stable for a number of years and continues to rise as new products are launched.

News about Smith & Nephew (SN.)

Broker Forecast - Goldman Sachs issues a broker note on Smith & Nephew PLC

News - Wednesday, January 15, 2020

Goldman Sachs today reaffirms its neutral investment rating on Smith & Nephe......

Broker Forecast - Goldman Sachs issues a broker note on Smith & Nephew PLC

News - Wednesday, November 13, 2019

Goldman Sachs today reaffirms its neutral investment rating on Smith & Nephe......

FTSE 100 Latest
Value7,674.56
Change64.75


Login to your account

Forgot Password?

Not Registered